These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 575633)

  • 1. Potency testing of pertussis immunoglobulins, relationship between neutralisation test and agglutination test.
    Schneider W; Sabin S; Schwanig M
    Dev Biol Stand; 1979; 44():125-8. PubMed ID: 575633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Passive protection tests in the mouse with pertussis immunoglobulin (author's transl)].
    Sabin S; Schwanig M
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):268-74. PubMed ID: 228513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Duration of efficiency of pertussis immunoglobulin in the passive protection tests in mice (author's transl)].
    Sabin S; Schwanig M; Schneider W
    Zentralbl Bakteriol A; 1981; 249(2):254-60. PubMed ID: 6267844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency tests for pertussis vaccines: doubtful value of intracerebral challenge test in mice.
    Preston NW
    J Pathol Bacteriol; 1966 Jan; 91(1):173-9. PubMed ID: 5941389
    [No Abstract]   [Full Text] [Related]  

  • 7. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 8. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency assay and characterization of lymphocytosis promoting factor in whole cell and acellular pertussis vaccines.
    Tiru M; Falk A; Brym-Grynblat B; Pettersson IM
    Dev Biol Stand; 1991; 73():157-65. PubMed ID: 1778309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
    van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
    Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.
    Xing D; Canthaboo C; Douglas-Bardsley A; Yuen CT; Prior S; Liu Y; Corbel M
    Dev Biol (Basel); 2002; 111():57-68. PubMed ID: 12678225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological diagnosis of whooping cough.
    Finger H; Wirsing von Koenig CH
    Dev Biol Stand; 1985; 61():331-5. PubMed ID: 2872121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
    Mills KH; Brady M; Ryan E; Mahon BP
    Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pertussis: study of 200 cases in childhood].
    Colli R; Bianchi G; Frigerio G; Viganò F
    Minerva Pediatr; 1983 Jul; 35(13-14):711-6. PubMed ID: 6646094
    [No Abstract]   [Full Text] [Related]  

  • 15. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agglutinin response against pertussis vaccine in mice.
    Saran G; Angra SS; Sahai G; Balasubrahmanyan M
    Indian J Med Res; 1979 Dec; 70():868-74. PubMed ID: 541012
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in pertussis vaccines leading to reduction and replacement of in vivo testing.
    Redhead K
    Dev Biol Stand; 1996; 86():263-70. PubMed ID: 8785955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland.
    Gzyl A; Augustynowicz E; Rabczenko D; Gniadek G; Slusarczyk J
    Biologicals; 2004 Sep; 32(3):129-37. PubMed ID: 15536043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.